CDC: ~65% of US Women Currently Using Contraceptives

December 21, 2018

Almost two-thirds of US women aged 15 to 49 years were currently using contraception in 2015 to 2017.

Five-Year Efficacy Data Announced for Liletta Intrauterine System

By December 10, 2018

Phase 3 trial results assessing the intrauterine system, Liletta (levonorgestrel 52mg), found that it had >99% efficacy in preventing pregnancy for up to 5 years; the products current Food and Drug Administration indication.

FDA to Review Estrogen-Free Oral Contraceptive Slinda

By November 30, 2018

Drospirenone is a spironolactone analogue with antimineralocorticoid and antiandrogenic activity.

Male Contraceptive Gel to Be Evaluated in Clinical Trial

By November 29, 2018

The year-long Phase 2b trial, funded by the National Institutes of Health, will enroll approximately 420 couples that are seeking pregnancy prevention across 3 US sites (Los Angeles, Seattle, and Kansas City).

Trump Administration Finalizes Birth Control Coverage Opt-Out

November 09, 2018

Women's rights groups sued the Trump administration over an earlier version of the change and say they will continue their legal fight, the AP reported.

Oral Contraceptives Recalled Due to Incorrect Dispenser Instructions

By November 05, 2018

Without proper instructions for the correct use of the Veridate dispenser pack, the patient may take the pills in the wrong order or may take an inactive "reminder" pill vs an "active" pill.

Liletta Now Approved for Pregnancy Prevention for Up to 5 Years

By October 16, 2018

The expanded approval was supposed by safety and efficacy data from the Phase 3 ACCESS IUS trial (N=1751) in women receiving Liletta. In the trial, Liletta demonstrated >99% efficacy in preventing pregnancy for up to 5 years in a broad patient population.

Newer Hormonal Contraception May Cut Ovarian Cancer Risk

September 27, 2018

The researchers identified 1249 incident ovarian cancers during 21.4 million person-years; 478 ovarian cancers were recorded among 13,344,531 person-years for ever users of hormonal contraception, while never users had 771 ovarian cancers during 8,150,250 person-years.

FDA Approves First Mobile App for Use in Preventing Pregnancy

By August 13, 2018

The algorithm was designed to account for sperm survival, variation in cycle length, ovulation day, temperature fluctuations and the length of the follicular and luteal phases of the menstrual cycle.

Self-Administered Contraceptive Vaginal System Approved for Up to 1 Year of Use

By August 13, 2018

The safety and efficacy of Annovera was evaluated in 3 open-label clinical trials involving healthy women (ages 18 to 40).

Essure System for Permanent Birth Control to Be Discontinued

By July 20, 2018

The Company maintains that the safety and efficacy of the device remains consistent and that the reason for this discontinuation is strictly business-related.

Oral Contraceptive Taytulla Recalled Due to Packaging Error

By May 29, 2018

A physician report indicates that 4 placebo (non-hormonal) capsules were placed in the first 4 days of therapy instead of active capsules.

Most Teens, Young Women Satisfied With IUD Insertion

May 18, 2018

The researchers found that 76.8% of the participants reported high overall satisfaction with the procedure and that 67.4% reported that they would recommend an IUD to a friend.

CDC: Number of US Births Dropped to 30-Year Low in 2017

May 17, 2018

For teenagers aged 15 to 19 years, the birth rate decreased 7% in 2017 to 18.8 births per 1,000 women, with decreases in the rates for younger and older teenagers (15 to 17 and 18 to 19, respectively).

Prescription Med Use in Children Down Overall From 1999 to 2014

May 16, 2018

Asthma medications, antibiotics, attention-deficit/hyperactivity disorder (ADHD) medications, topical agents, and antihistamines were the most commonly used medication classes in 2011 to 2014.

Emergency Contraceptive Preventeza Now Available Over-the-Counter

By May 08, 2018

Preventeza can be taken within 72 hours of unprotected sex or contraceptive failure although it is most effective the sooner it is taken.

Long-Acting Reversible Contraceptives Good for Teens

April 27, 2018

Patients' lack of familiarity with or understanding of these methods, potentially high cost of initiation, lack of access, low parental acceptance, and obstetrician-gynecologists' and other health care providers' misconceptions about LARC safety in adolescents are barriers to LARC use.

ACOG: Revised Committee Opinion on Postpartum Care Released

By April 25, 2018

Previously, ACOG had recommended a comprehensive postpartum visit occur within the first 6 weeks after birth.

CDC: Birth Rate for 10- to-14-Year-Olds at Record Low in 2016

April 25, 2018

During the same time period, birth rates declined for females aged 10 to 14 years for all race and Hispanic-origin groups, with non-Hispanic black females having the largest decline.

Number of IUD Insertions Up After ACA Contraceptive Mandate

April 10, 2018

"Women in plans with the greatest reduction in out-of-pocket cost after mandated coverage of contraception had the greatest gains in IUD insertion," the authors write.

FDA Puts New Restrictions on Permanent Birth Control Implant Essure

By April 09, 2018

The new Essure labeling restricts the sale and distribution of the device to only health care providers and facilities that provide information to patients about the risks and benefits of this device.

Male Birth Control Pill Moves 'Step Closer' Following Safety Trial

March 19, 2018

Suppression of follicle stimulating hormone and luteinizing hormone was reported for all subjects in the P400mg group and 12 of 13 subjects in the C400mg group. No significant change was seen in mood.

Progestin-Only Contraceptives and Depression: Is There a Link?

By February 28, 2018

Study quality was graded according to the United States Preventive Services Task Force and the Cochrane Risk of Bias Tools.

Toxic Plant Extract Shows Promise in Early Male Birth Control Studies

February 02, 2018

While the male hormonal birth control pill option is in clinical human trials and likely closer to market, it has several potential side effects: In addition to potentially causing weight gain and changes in libido.

Oral Contraceptive Balcoltra Gets FDA Approval

By January 17, 2018

Balcoltra is the only branded contraceptive that combines levonorgestrel 0.1mg and ethinyl estradiol 20mcg with ferrous bisglycinate 36.5mg.

PMS/PMDD: A Review of Treatment Options

By January 04, 2018

Recent data regarding the treatment of premenstrual syndrome/premenstrual dysphoric disorder (PMS/PMDD) has "triaged therapy options into first, second, third, and last lines."

Few CA Pharmacies Offer RPh-Prescribed Contraception, Despite Law

By December 13, 2017

The law, enacted in 2013 and implemented in 2016, allows pharmacists to prescribe birth control to increase access to oral contraceptives, patches, rings, and injections for women.

Hormonal Contraceptives and Breast Cancer: What's the Link?

December 07, 2017

Findings from nationwide study in Denmark show small absolute increase in breast cancer risk

IUD Use and Cervical Cancer Risk: What's the Link?

By November 09, 2017

The data showed women who used IUD had a lower occurrence of cervical cancer (odds ratio [OR] 0.64, 95% CI: 0.53-0.77).

ACOG: Recommendations for LARC Initiation and Management

October 26, 2017

Insertion of IUD should be offered after first-trimester uterine aspiration, on same day as abortion